SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine -- Ignore unavailable to you. Want to Upgrade?


To: Don W Stone who wrote (220)1/16/1998 1:06:00 AM
From: Don W Stone  Read Replies (1) | Respond to of 507
 
To all: Here are some comments that were recently attributed to "Liz Greetham, portfolio manager for Weiss Peck & Greer" which should be conforting to any NVX bull.
For those who aren't aware of it, this I think is the second largest institutional holder of NVX stock. Those that know Liz Greetham have told me that she is very well respected on Wall Street.

She said that she does not think that this latest FDA request for information will turn into a major skirmish.
Greetham said that this data request came from the FDA division that oversees biological drugs, which is clamping down on its manufacturing requirements. She said that NVX's competitors that have pertussis products on the market got warning letters about manufacturing from the FDA.
She said the data the FDA wants isn't safety or efficacy data.
She said that it is her understanding from conversations with Abbott and NVX that the Label is done.
That the request for information is probably an analytics question.

I have only tried to convey what I think she mite have tried to convey in a recent interview.
Now here are my comments. What is significant here is the comment that the FDA Biologics group is clamping down on its manufacturing requirements and that all of NVX's competitors got "warning letters" from the FDA regarding manufacturing. I have heard that they got them recently. What this is about at this stage is perhaps premature but my best guess is the older manufacturing companies i.e. Connaugh, SKB,
Lederle, are being required to meet the latest FDA manufacturing requirement.( I liken all this to like dealing with local or state fire codes , etc. abit more stringent I would hope and assume.:-} ) How difficult will it be for the older companies to meet the new requiremnts is up for contemplation.( bringing an old building up to todays building code sometimes means , teardown) Meanwhile I would say NVX who in the last two years has been meeting regularly with the FDA and completed and put on line the most advanced manufacturing facitity in the world to produce their pertussis vaccine should be able to readily conform . If I really wanted to take this to the extreme I could argue that NVX just could become the sole source provider of pertussis vaccine by default.
My point is that I am hearing that many think that this lastest news release, this request for more information from the FDA just may be related to the above and concerns a notice of a new standard or procedure involving manufacturing of the pertussis vaccine that can be readily met by NVX. It can't be all that bad if the Company is saying that the information is in house and that all of it will be in the hands of the FDA over the next two weeks.
Enough for tonite. The shorts i am told shorted over 50,000 shares today in their effort to drive the price of the stock down. They know their window is very small. This is why they are out USING the media.
The time to BUY is now. Make them pay. Of course if a big holder just calls his stock this situation will reverse.



To: Don W Stone who wrote (220)1/16/1998 11:16:00 AM
From: Don W Stone  Respond to of 507
 
To All:Buried in the BS and lies and distortions and other crap in "the street " article on monday was significant input on what fridays NVX press release was all about.

The FDA requested additional information according to fridays press release.
What is the first question that comes to mind?
What type of information? Well we were given one persons input of her take on what is going on and the answer to that question. I know several people who read the article and didn't go away with what was really conveyed. If you were a BEAR you relished in all the false statements, inuuendos, etc. that supported what you wanted to believe. If you were a bull you were so enraged by the false statements and other crap that you could not sort anything out worthy of knowing.
The article was about the lead NVX BEAR and a Reporter versus a top level portfolio manager,an NVX BULL on WS. Needless to say in the obvious absence of " OBJECTIVITY", no make that "honest objectivity" what message do you think gets conveyed?
You got it . The one that isn't really worth very much.
We are talking here about SOURCE CREDIBILITY. Mark Haines on CNBC hit on it this morning and I think he was refering to the same source .
If someone else happen to catch his statement then can confirm or deny.
'"Objectivity, Insight, Accountability", "reporting that holds people accountable".
" Things aren't so easy to find like honest objective coverage". (These are not my quotes but they should ring a familiar bell to some who read this).
The only place I have truly found the goals expressed in these quotes is over on the MOTLEY FOOLS. I may not like or agree with what they have to say but I am hard pressed to pick them Apart. The article I have referenced here I could literally shred to pieces. :-}
Yes . The shorts are had big time, they will keep making noise , and there will be yet another new news media on the block ready for the taking. Sad , but true.
NVX has approval in the bag and the shorts know it. That is why all of a sudden the shorts have shifted their argument once again. They are all about "fantasy". The latest short thinking: you are never wrong on WS , you are just off on timing. but INFINITY? :-}